Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05524181 · ClinicalTrials.gov registry record · NA

Telehealth-enabled Integrated Palliative Care for People With Dementia

A NA study of Alzheimer Disease and Dementia of Alzheimer Type, sponsored by Thomas Jefferson University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05524181 is a NA study of Alzheimer Disease and Dementia of Alzheimer Type that has completed, run by Thomas Jefferson University. The registered enrollment target is 50 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05524181, a NA study of Alzheimer Disease and Dementia of Alzheimer Type, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

In prior work, this team developed a telehealth primary care model (TIPC), designed in close partnership with patients and clinicians to address a widespread increase in telehealth use during the COVID-19 pandemic. This research team will test the TIPC intervention to assess support for patients among a population of persons with dementia (PwD). Participants will be enrolled in the study for a 12 month period. This study's aims are 1) to explore the impact of the TIPC intervention on patient-important outcomes, engagement with community-based support provided through insurers, advanced care planning (primarily identification of health-care proxy), and patterns of hospice and healthcare utilization in the target population and 2) to evaluate patient, caregiver, and clinical team perspectives of feasibility and acceptability of a TIPC model, and apply findings from this work to the development of a larger randomized control trial designed to assess long-term efficacy of TIPC intervention.

Interventions

  • OTHER Telehealth Integrated Primary Care (TIPC)

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-06-29
Est. Completion 2024-11-14
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT05524181

The ClinicalTrials.gov registry entry for NCT05524181 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Telehealth Integrated Primary Care (TIPC) is the first listed.

NCT05524181 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05524181 about?

NCT05524181 is a clinical study titled "Telehealth-enabled Integrated Palliative Care for People With Dementia". In prior work, this team developed a telehealth primary care model (TIPC), designed in close partnership with patients and clinicians to address a widespread increase in telehealth use during the COVID-19 pandemic. This research team will test the TIPC intervention to assess support for patients amo...

What is the current status of trial NCT05524181?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-06-29. Estimated completion is 2024-11-14.

What conditions does trial NCT05524181 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia of Alzheimer Type, Vascular Dementia, Lewy Body Dementia, Vascular Cognitive Impairment.

What interventions are being tested in trial NCT05524181?

The interventions under investigation include: Telehealth Integrated Primary Care (TIPC) (OTHER).

Who is sponsoring clinical trial NCT05524181?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05524181 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.